CareScience Mortality Risk Model

Presentations from a November 2008 meeting to discuss issues related to mortality measures.

Calibration Data (continued)

Diag	Description	% Cases	Mortality			Morbidity			Complications
Diag	Description	% Cases	Rate	Factors	FIT	Rate	Factors	FIT	Rate	Factors	FIT
507	Pneumonitis due to solids/liquids	0.45%	13.2%	27	0.119	27.1%	48	0.384	59.3%	50	0.317
511	Pleurisy	0.16%	3.8%	22	0.113	21.7%	30	0.404	56.6%	33	0.283
512	Pneumothorax	0.11%	2.5%	20	0.151	9.4%	27	0.436	32.3%	30	0.342
515	Fibrosis postinflammatory pulmonary	0.07%	7.0%	21	0.132	21.9%	26	0.442	47.6%	34	0.335
518	Diseases, lung, other	1.03%	18.0%	42	0.200	41.0%	48	0.410	69.7%	66	0.356
531	Ulcer, gastric	0.23%	2.2%	23	0.159	12.2%	41	0.455	52.2%	48	0.308
532	Ulcer, duodenal	0.16%	3.6%	26	0.160	14.4%	35	0.479	52.9%	46	0.326
535	Gastritis and duodenitis	0.31%	0.6%	20	0.045	8.7%	30	0.213	42.5%	41	0.242
540	Appendicitis, acute	0.68%	0.2%	20	0.062	3.0%	25	0.503	16.0%	29	0.355
557	Insufficiency, vascular, intestine	0.16%	9.7%	33	0.218	22.3%	42	0.441	59.5%	40	0.306
560	Obstruction, intestinal w/o hernia	0.79%	2.7%	40	0.110	9.9%	49	0.447	40.6%	66	0.324
567	Peritonitis	0.06%	4.1%	26	0.140	12.8%	34	0.469	48.4%	31	0.343
569	Disorders, intestine, other	0.28%	3.5%	54	0.178	14.6%	56	0.448	50.8%	61	0.326
571	Disease and cirrhosis, liver, chrn	0.26%	8.1%	26	0.176	18.3%	41	0.371	57.6%	40	0.283
572	Abscess and disease sequelae, liver	0.14%	8.5%	26	0.192	17.0%	28	0.433	54.5%	36	0.303
574	Cholelithiasis	0.87%	0.6%	37	0.077	8.2%	40	0.517	32.5%	56	0.379
577	Diseases, pancreas	0.71%	1.1%	28	0.138	8.0%	41	0.480	38.8%	50	0.322
578	Hemorrhage, gastrointestinal	0.43%	3.8%	23	0.155	12.5%	44	0.472	52.9%	43	0.301
584	Renal failure, acute	0.91%	5.6%	44	0.107	19.8%	56	0.411	53.3%	56	0.319
585	Renal failure, chronic	0.04%	7.6%	26	0.378	15.1%	21	0.472	53.2%	26	0.322
590	Infections, kidney	0.31%	0.3%	14	0.024	6.0%	31	0.353	25.5%	32	0.346
592	Calculus, kidney and ureter	0.40%	0.1%	15	0.048	2.6%	35	0.199	15.2%	31	0.256
599	Disorder, urethra/urinary tract oth	0.92%	1.3%	27	0.027	10.1%	49	0.380	32.7%	50	0.288
682	Cellulitis and abscess, other	1.31%	0.4%	28	0.039	3.6%	41	0.418	23.6%	63	0.336
707	Ulcer, chronic, skin	0.17%	2.2%	33	0.063	10.6%	63	0.422	45.8%	65	0.362
715	Osteoarthrosis and allied disorders	2.25%	0.1%	15	0.045	2.5%	37	0.250	32.0%	66	0.172
721	Spondylosis and allied disorders	0.32%	0.2%	17	0.059	3.2%	37	0.392	22.3%	51	0.375
722	Disorders, intervertebral disc	1.06%	0.1%	20	0.078	1.9%	43	0.329	18.5%	55	0.360
724	Disorders, back, other & unspc	0.44%	0.2%	22	0.070	3.3%	35	0.399	30.1%	47	0.339
730	Infections involving bone	0.14%	0.8%	21	0.061	8.4%	57	0.462	38.4%	70	0.381
733	Disorders, bone and cartilage	0.44%	0.9%	34	0.067	5.7%	43	0.413	33.7%	66	0.333
780	Symptoms, general	1.62%	0.5%	31	0.031	4.1%	45	0.331	28.8%	60	0.249
784	Symptoms involving head and neck	0.15%	0.4%	11	0.032	4.5%	28	0.434	32.4%	36	0.290
785	Symptoms inv cardiovascular system	0.07%	3.3%	22	0.390	8.0%	32	0.621	39.7%	45	0.357
786	Symptoms inv respiratory syst/chest	2.26%	0.1%	21	0.018	2.0%	41	0.248	19.3%	49	0.248
787	Symptoms involving digestive system	0.23%	0.7%	19	0.026	6.1%	29	0.396	43.3%	40	0.246
789	Symptoms inv abdomen, pelvis, other	0.50%	0.5%	21	0.038	5.8%	32	0.136	35.5%	38	0.244
805	Fx, vrt column w/o spinal crd inj	0.27%	1.3%	30	0.105	7.3%	42	0.513	36.8%	57	0.366
807	Fracture Rib/Sternum/Larynx/Trachea	0.10%	1.8%	23	0.113	9.2%	27	0.489	36.8%	41	0.370
808	Fracture, pelvis	0.15%	1.4%	24	0.094	7.6%	33	0.503	36.3%	43	0.371
851	Laceration and contusion, cerebral	0.06%	8.8%	40	0.374	14.4%	35	0.445	41.5%	35	0.479
852	Hemorrhage, intracranial post-inj	0.19%	11.1%	42	0.371	15.3%	38	0.468	44.9%	46	0.444
965	Poisoning analgesics/antirheumatics	0.17%	1.7%	17	0.221	18.7%	26	0.634	48.9%	33	0.377
969	Poisoning by psychotropic agents	0.20%	0.7%	8	0.139	17.2%	18	0.644	45.9%	28	0.378
996	Complication peculiar to procedures	1.55%	1.8%	53	0.109	12.0%	78	0.488	45.9%	106	0.328
997	Complication affecting body NEC	0.33%	1.6%	39	0.134	16.2%	59	0.478	49.1%	64	0.307
998	Complications of procedures NEC	0.72%	1.0%	24	0.106	7.8%	51	0.492	36.2%	70	0.360
DRG103		0.01%	21.6%	13	0.199	59.8%	14	0.420	91.3%	11	0.227
DRG480		0.01%	5.3%	9	0.079	30.9%	18	0.364	72.2%	19	0.283
DRG481		0.02%	6.5%	12	0.320	13.8%	14	0.554	62.2%	20	0.375
DRG495		0.00%	4.2%	6	0.135	39.9%	5	0.201	82.5%	7	0.225
DRG512		0.00%	2.1%	4	0.134	17.0%	11	0.647	69.2%	9	0.339
DRG513		0.00%	2.2%	1	.	13.0%	8	0.724	63.6%	5	0.358
Femur_	Femur_Fracture	0.97%	2.5%	38	0.108	13.7%	48	0.469	56.7%	60	0.281
Hernia	Hernia	0.48%	1.1%	28	0.118	8.9%	38	0.500	34.4%	52	0.352
Hyperte	Hypertensive	0.51%	2.5%	39	0.094	23.9%	49	0.570	51.4%	53	0.398
Immatur	Immature_Neonates	1.27%	3.0%	16	0.356	na	na	na	na	na	na
Leukemi	Leukemia	0.10%	16.9%	20	0.203	20.8%	27	0.446	54.4%	34	0.378
Normal_	Normal_Neonates	9.66%	0.1%	23	0.009	na	na	na	na	na	na
Skull_Fr	Skull_Fracture	0.12%	9.5%	40	0.240	12.4%	35	0.404	35.9%	37	0.497
V55	Attention to artificial openings	0.11%	0.7%	24	0.071	8.6%	34	0.483	41.4%	40	0.335
V57	Care, rehabilitation procedures	1.54%	0.6%	32	0.015	10.9%	46	0.410	51.3%	49	0.289
V58	Aftercare	0.45%	1.4%	38	0.122	4.2%	37	0.457	23.3%	47	0.407
BDG1	Infectious and Parasitic Diseases	0.65%	1.7%	36	0.130	8.0%	51	0.485	30.9%	55	0.402
BDG2	Neoplasma	1.79%	2.3%	61	0.151	6.7%	78	0.400	29.4%	102	0.337
BDG3	Endocrine, Nutritional, Metabolic, and	0.72%	0.8%	32	0.073	5.8%	51	0.437	27.5%	65	0.343
BDG4	Diseases of Blood and Blood-Forming	0.25%	2.8%	33	0.128	10.4%	49	0.456	39.3%	44	0.388
BDG5	Mental Disorders	1.82%	0.2%	41	0.024	2.8%	51	0.325	23.3%	56	0.374
BDG6	Diseases of Nervous System and Sense	0.89%	1.0%	44	0.090	5.0%	57	0.477	29.3%	78	0.358
BDG7	Diseases of the Circulatory System	0.85%	2.8%	52	0.128	14.5%	64	0.480	44.1%	90	0.382
BDG8	Diseases of the Respiratory System	0.66%	1.6%	40	0.101	10.7%	54	0.480	33.3%	63	0.423
BDG9	Diseases of the Digestive System	2.90%	0.9%	52	0.095	8.6%	60	0.315	35.2%	75	0.320
BDG10	Diseases of the Genitourinary System	2.02%	0.2%	39	0.045	2.8%	59	0.430	23.8%	82	0.259
BDG11	Complications of Pregnancy and	12.30%	0.0%	33	0.020	2.3%	51	0.034	53.6%	58	0.432
BDG12	Diseases of Skin and Subcutaneous Tiss	0.21%	0.4%	25	0.070	3.4%	36	0.479	20.9%	49	0.342
BDG13	Musculoskeletal and Connective Tissue	0.95%	0.5%	26	0.061	4.8%	50	0.457	28.5%	78	0.367
BDG14	Congenital Anomalies	0.28%	0.9%	33	0.092	6.0%	56	0.334	28.6%	85	0.345
BDG16	Symptoms, Signs, and Ill-Defined	0.42%	2.0%	35	0.111	8.1%	50	0.457	40.8%	60	0.359
BDG17	Injury and Poisoning	2.64%	1.5%	69	0.137	7.3%	79	0.487	30.2%	104	0.397
BDG18	Factors Influencing Health Status	0.25%	2.9%	27	0.480	4.6%	42	0.534	24.3%	64	0.393

Current as of February 2009

Return to Article Contents
Return to Mortality Measurement Contents
Proceed to Next Section

Page last reviewed March 2009

Internet Citation: CareScience Mortality Risk Model. March 2009. Agency for Healthcare Research and Quality, Rockville, MD. http://archive.ahrq.gov/professionals/quality-patient-safety/quality-resources/tools/mortality/KrochMort3.html